David Eve serves as Chief Business Development Officer at Ionetix, overseeing the Company’s business development and commercial strategy across its diagnostic and therapeutic isotope portfolio. He joined Ionetix in 2013, initially leading the company’s sales and nuclear cardiology business development efforts. Before assuming his current role, Mr. Eve served as Vice President of Medical Affairs, supporting clinical and scientific engagement with customers, key opinion leaders (KOLs), and partners.

Prior to Ionetix, Mr. Eve was Vice President of Operations and Strategic Development at Soteria Imaging Services, LLC, a national leader in outpatient medical imaging. His previously roles included Vice President of Technical Services, Vice President of PET Operations and Director of Facility Operations. Mr. Eve earned his B.S. in Nuclear Medicine from Wheeling Jesuit University.